History
  • No items yet
midpage
BRANDYWINE HOSPITAL, LLC v. CVS HEALTH CORPORATION
2:23-cv-01458
| E.D. Pa. | Feb 26, 2025
Read the full case

Background

  • Brandywine Hospital, a 340B "Covered Entity," filed a putative class action against CVS Health (including subsidiaries) alleging antitrust violations related to the 340B Drug Pricing Program.
  • The 340B Program allows certain healthcare providers to buy outpatient drugs at discounted prices, often relying on "Contract Pharmacies" like CVS and third-party administrators (TPAs) for program administration.
  • Brandywine alleged that after CVS acquired TPA Wellpartner, CVS forced Covered Entities to use Wellpartner as a condition of accessing 340B savings at CVS pharmacies, supposedly foreclosing other TPAs from competition.
  • Plaintiff asserted this conduct constituted an illegal tying arrangement under Sections 1 and 2 of the Sherman Act and Section 3 of the Clayton Act.
  • CVS moved to dismiss for failure to state a claim, and Brandywine conceded its Clayton Act claim should be dismissed.
  • The Court determined whether Brandywine had plausibly pled a valid tying claim under the Sherman Act, either under per se or rule of reason analysis.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Proper Market Definition (Per Se Tying) “CVS Contract Pharmacy Market” is a valid single-brand market due to 340B program structure Single-brand markets are improper; other pharmacies are interchangeable Plaintiff failed to define a proper market; per se claim dismissed
Interchangeability and Cross-Elasticity No other pharmacies are interchangeable; no cross-elasticity as Covered Entities can’t steer patients Entities can and do contract with non-CVS pharmacies; 2010 Guidance does not bar such switches Court found market incorrectly defined; no non-interchangeability shown
Rule of Reason – Anticompetitive Effect Harm exists via loss of choice and inflated prices for TPA services at CVS Harm allegations are only for a subset (CVS-linked TPAs), not the TPA market as a whole Court found no market-wide impact; allegations too narrow
Adequacy of Clayton Act Claim No substantive argument (Plaintiff conceded) Conceded (should be dismissed) Dismissed with prejudice

Key Cases Cited

  • Ashcroft v. Iqbal, 556 U.S. 662 (pleading standard for plausibility)
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausible claim of relief required)
  • Queen City Pizza, Inc. v. Domino’s Pizza, Inc., 124 F.3d 430 (market definition requires interchangeability)
  • Warren Gen. Hosp. v. Amgen Inc., 643 F.3d 77 (criteria for per se tying arrangements)
  • Town Sound & Custom Tops, Inc. v. Chrysler Motors Corp., 959 F.2d 468 (single-brand tying markets are disfavored)
Read the full case

Case Details

Case Name: BRANDYWINE HOSPITAL, LLC v. CVS HEALTH CORPORATION
Court Name: District Court, E.D. Pennsylvania
Date Published: Feb 26, 2025
Docket Number: 2:23-cv-01458
Court Abbreviation: E.D. Pa.